CATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturing
The Canadian Advanced Therapies Training Institute (CATTI) and the Cell and Gene Therapy Catapult (CGT Catapult) have developed an aligned training and assessment strategy for the advanced therapies manufacturing industry. The strategy is an important first step towards developing shared standards that will help the growing industry to access a skilled workforce.
Published on the 30th of May 2024. Read the entire news report here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (4 novembre 2024). CATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturing. ELSIBI. Consulté le 10 décembre 2024 à l’adresse https://doi.org/10.58079/12m6z
